aTyr Pharma | LIFE - Net Income


aTyr Pharma reported $-25.74M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -5.77M 2.26M Jun/2023
Ardelyx USD -969K 18.11M Sep/2025
aTyr Pharma USD -25.74M 6.21M Sep/2025
Biogen USD 466.5M 168.3M Sep/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Cipla INR 6.76B 6.75B Dec/2025
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD -6.98M 360K Sep/2025
CSL USD 401M 96.5M Dec/2025
Curis USD -11.8M 80K Jun/2024
Galapagos EUR 782.15M 984.26M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Grifols EUR 148.4M 15.76M Sep/2025
Novartis USD 3.93B 96M Sep/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
United Therapeutics USD 364.3M 25.6M Dec/2025
Xoma USD -17.24M 33.23M Sep/2024